BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33854347)

  • 1. Unfavorable Treatment Outcome and Its Predictors Among Patients with Multidrug-Resistance Tuberculosis in Southern Ethiopia in 2014 to 2019: A Multi-Center Retrospective Follow-Up Study.
    Bogale L; Tsegaye T; Abdulkadir M; Akalu TY
    Infect Drug Resist; 2021; 14():1343-1355. PubMed ID: 33854347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
    Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z
    PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study.
    Bade AB; Mega TA
    PLoS One; 2020; 15(11):e0241684. PubMed ID: 33166299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to sputum culture conversion and its determinants among Multi-drug resistant Tuberculosis patients at public hospitals of the Amhara Regional State: A multicenter retrospective follow up study.
    Yihunie Akalu T; Muchie KF; Alemu Gelaye K
    PLoS One; 2018; 13(6):e0199320. PubMed ID: 29927980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study.
    Watumo D; Mengesha MM; Gobena T; Gebremichael MA; Jerene D
    BMC Public Health; 2022 May; 22(1):976. PubMed ID: 35568853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study.
    Woldeyohannes D; Tekalegn Y; Sahiledengle B; Assefa T; Aman R; Hailemariam Z; Mwanri L; Girma A
    PLoS One; 2021; 16(5):e0250804. PubMed ID: 33956812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study.
    Tola H; Holakouie-Naieni K; Mansournia MA; Yaseri M; Gamtesa DF; Tesfaye E; Mahamed Z; Sisay MM
    BMJ Open; 2021 Aug; 11(8):e040862. PubMed ID: 34376436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study.
    Molie T; Teklemariam Z; Klinkenberg E; Dessie Y; Kumsa A; Mohammed H; Debebe A; Assefa D; Habte A; Bedru A; Fiseha D; Seyoum B
    BMC Infect Dis; 2019 Sep; 19(1):818. PubMed ID: 31533644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of mortality among multidrug-resistant tuberculosis patients in central Ethiopia: a retrospective follow-up study.
    Kassa GM; Tadesse A; Gelaw YA; Alemayehu TT; Tsegaye AT; Tamirat KS; Akalu TY
    Epidemiol Infect; 2020 Oct; 148():e258. PubMed ID: 33054897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter's Specialized Hospital, Addis Ababa, Ethiopia.
    Muluneh MA; Zeru AB; Derseh BT; Molla Kebede A
    Can J Infect Dis Med Microbiol; 2021; 2021():6696199. PubMed ID: 34527088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.
    Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC
    Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study.
    Merid MW; Gezie LD; Kassa GM; Muluneh AG; Akalu TY; Yenit MK
    BMC Infect Dis; 2019 Mar; 19(1):286. PubMed ID: 30917788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of death among drug-resistant tuberculosis patients in Kuala Lumpur, Malaysia: A retrospective cohort study from 2009 to 2013.
    Mohd Shariff N; Shah SA; Kamaludin F
    J Glob Antimicrob Resist; 2016 Sep; 6():102-107. PubMed ID: 27530850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of body weight change on treatment outcomes in patients with multidrug-resistant tuberculosis in Northwest Ethiopia.
    Wagnew F; Alene KA; Kelly M; Gray D
    Sci Rep; 2024 Jan; 14(1):508. PubMed ID: 38177234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Unfavorable Outcomes of Tuberculosis in Korea: Implications for Patient-Centered Care in Tuberculosis Treatment.
    Hong HY; Park Y; Yong SH; Woo A; Leem AY; Lee SH; Chung KS; Lee SH; Kim SY; Kim EY; Jung JY; Park MS; Kim YS; Shin SJ; Kang YA
    J Korean Med Sci; 2024 Jan; 39(2):e4. PubMed ID: 38225780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and predictors of treatment interruption among patients on anti-tuberculosis treatment in Nekemte public healthcare facilities, Oromia, Western Ethiopia.
    Getachew RG; Tolossa T; Teklemariam Z; Ayele A; Roba HS
    Front Epidemiol; 2023; 3():1234865. PubMed ID: 38455888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.